Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

We might have seen a p&d but we must admit:

1) volume approached 8mm in two days (maybe too much even for more than one chat room);

2) we have seen the potential with this low float (11mm O/S) if a solid news will be released;

3) stock at these levels is massively undervalued. Less then 30mm market cap for a potential blockbuster drug and a very promising oncological drug

4) pps could hold the 2,5$ (still up 50% since last week) price recently accepted by TyrNovo investors. About that, my question is: would have you accepted shares at 2,5 (when it was traded at 1,9) instead of cash if you didn’t know what was their plan?

I think that the proposals recently approved and this restructuring (merging between the holding and the subsidiary) is part of something big in the future. In other words, it could be related to some deal. As we know, US and EU deal are ongoing.

In the meanwhile, we have to wait Renal results that if positive could give to KIT-302 a great value added.

Good luck!